PDGFRB and colorectal cancer: Recently, a case of a patient with colorectal cancer harboring strong PDGFR-β expression due to a newly described germline PDRFR-β mutation c.17C>T (NM_002609.3) was reported with substantial clinical response to regorafenib as compared to non-mutated colorectal cancer patients [59].